Following the reports of unusually high incidences of chills in several dialysis centers in Manila, Bulacan, Valenzuela and Batangas, the Food & Drug Administration (FDA) after due investigations has issued a recall order on the blood anti-coagulant Meparin 5 and Meparin 25. This brand of Heparin Sodium manufactured by MedChem International Ltd has been found to have been contaminated by an undisclosed bacterial specie. Further investigations on other parenteral products of MedChem are underway.
The Department of Health (DOH) therefore enjoins all hospitals, dialysis centers and clinics to refrain from using Meparin 5 and Meparin 25, and to report to the FDA or DOH any suspicious clustering of symptoms such as the those experienced by the hospitals & dialysis centers in the above-mentioned areas.
Consumers may contact Pharma-Surrey International Inc at telephone number +6324128364, or e-mail at email@example.com. Consumer may also email the FDA at firstname.lastname@example.org for any question or additional information regarding the product recall.